文献速递胸部肿瘤放疗放疗物理与技术

胸部SBRT后放射性肋骨骨折的剂量效应分析

Dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
PubMed 文献 · Radiother Oncol · 2017-01-19

最大肋骨剂量最能预测骨折,TD50为375Gy;当Dmax<225Gy时26个月症状性肋骨骨折风险<5%。

要点

  • 最大肋骨剂量是SBRT后肋骨骨折的最佳预测剂量参数
  • 基于全部数据并考虑毒性时间的NTCP模型TD50为375Gy
  • Dmax<225Gy时26个月症状性肋骨骨折风险<5%

核心结论

  • SBRT后症状性肋骨骨折风险与剂量显著相关,最大肋骨剂量最能预测骨折。
  • 基于全部数据并考虑毒性时间的NTCP模型TD50为375Gy。
  • 当Dmax<225Gy时,26个月症状性肋骨骨折风险<5%。

研究设计与样本

  • 采用自动肋骨勾画分析剂量效应关系,以Cox回归寻找预测骨折的最优EQD2校正剂量参数。
  • 基于最优参数构建三个NTCP模型:中位随访26个月模型、考虑毒性时间的全数据模型、排除低剂量肋骨的中位随访26个月模型。

主要发现

  • 骨折中位时间为22个月(范围5-51个月)。
  • 最大肋骨剂量最能预测骨折。
  • 第二个NTCP模型的TD50为375Gy,其他模型TD50显著更高,提示在中位随访时间或排除低剂量肋骨时低估了剂量效应。

关键数值与推荐

  • 基于全部数据并考虑毒性时间的NTCP模型TD50为375Gy。
  • Dmax<225Gy时26个月症状性肋骨骨折风险<5%。

临床怎么用

  • 胸部SBRT计划评估时应关注最大肋骨剂量,Dmax<225Gy时26个月症状性肋骨骨折风险<5%。
  • 剂量效应分析建议考虑随访时间及低剂量肋骨区域对NTCP模型的影响。

局限性

  • 在中位随访时间分析或排除低剂量肋骨时可能低估剂量效应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To determine a dose-effect relation for radiation induced rib fractures after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC). Automatic rib delineation has enabled the analysis of a large patient group. MATERIAL AND METHODS: Four-hundred and sixty-six patients with stage I/II NSCLC received SBRT with a median of 54Gy in 3 fractions. The optimal EQD2-corrected dose parameter to predict (a)symptomatic fractures was found using Cox regression. Three normal tissue complication probability (NTCP) models based on this optimal parameter were constructed: (1) at a median follow up (FU) of 26months, (2) for all data, with time to toxicity taken into account and (3) at a FU of 26months, excluding low dose ribs. RESULTS: The median time to fracture was 22 (range 5-51) months. Maximum rib dose best predicted fractures. The TD50 (dose with 50% complication) of the second NTCP model was 375Gy. The TD50 was significantly higher for the other models indicating an under-estimation of the dose effect at the median follow-up time and/or when excluding low dose ribs. CONCLUSIONS: The risk of symptomatic rib fractures after SBRT was significantly correlated to dose, and was <5% at 26months when Dmax<225Gy.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Stam B, van der Bijl E, Peulen H, et al. Dose-effect analysis of radiation induced rib fractures after thoracic SBRT. Radiother Oncol. 2017. PMID: 28110960. doi:10.1016/j.radonc.2017.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。